Delivery Order SPE2DB22D1106-SPE2DB24FFDL9

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DB22D2006|SPE2DB24FW0XV was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,804.69 firm fixed-price delivery order is for the supply of 4564837591 Klonopin 1 mg tablets. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,590.38 firm fixed-price delivery order is for the supply of 4565759095 Klonopin 0.5 mg tablets in 100-count bottles. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 11, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,136.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Klonopin 1 mg tablets, a prescription medication, to support the DLA's medical supply requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FM5Q4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.24 firm fixed-price delivery order is for the supply of 100-count bottles of the medication Klonopin (clonazepam) 0.5 mg tablets. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,406.10 firm fixed-price delivery order covers the supply of 4562819395 KLONOPIN 0.5 MG TABLET 100S, a common medication. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,300.46 firm fixed price delivery order is for the supply of 4565546861 units of the prescription drug Klonopin (0.5 mg tablets) with a completion date of August 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,505.45 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of KLONOPIN 1 MG TABLET 100S, a pharmaceutical product, with a completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and has an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of KLONOPIN 0.5 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,835.86 and a period of performance through June 6, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.76 Firm Fixed Price Delivery Order contract is for the supply of 4566895002 - KLONOPIN 0.5 MG TABLET 100S, a medication used to treat certain mental/mood disorders. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This...
This federal contract award (SPE2DB22D3102|SPE2DB25FK9AK) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.02 Firm Fixed Price delivery order contract is for the supply of KLONOPIN 0.5 MG TABLET 100S, a pharmaceutical product. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFDL9
    Delivery Order

This federal contract award, valued at $2,397.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Klonopin 0.5 mg tablets, with an ultimate completion date of July 24, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/17/25, 9:48 AM